222
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Essential oils in niosomes for enhanced transdermal delivery of felodipine

, &
Pages 157-165 | Received 23 Oct 2017, Accepted 12 Feb 2018, Published online: 23 Feb 2018

References

  • Abdelaziz AA, Elbanna TE, Sonbol FI, Gamaleldin NM, El Maghraby GM. 2015. Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation. Expert Opin Drug Deliv. 12:163–180.
  • Abdelkader H, Ismail S, Kamal A, Alany RG. 2010. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization. Pharmazie. 65:811–817.
  • Banga AK, Bose S, Ghosh TK. 1999. Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm. 179:1–19.
  • Barry BW. 1983. Dermatological formulations: percutaneous absorption. New York and Basel: Marcel Dekker.
  • Cevc G, Blume G. 1992. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1104:226–232.
  • Charoo NA, Anwer A, Kohli K, Pillai KK, Rahman Z. 2005. Transdermal delivery of flurbiprofen: permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino rats. Pharm Dev Technol. 10:343–351.
  • Chen J, Jiang QD, Wu YM, Liu P, Yao JH, Lu Q, Zhang H, Duan JA. 2015. Potential of essential oils as penetration enhancers for transdermal administration of ibuprofen to treat dysmenorrhoea. Molecules. 20:18219–18236.
  • Cornwell PA, Barry BW, Bouwstra JA, Gooris GS. 1996. Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies. Int J Pharm. 127:9–26.
  • Das S, Ng WK, Tan RB. 2012. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles(SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 47:139–151.
  • Diez I, Peraire C, Obach R, Domenech J. 1998. Influence of d-limonene on the transdermal penetration of felodipine. Eur J Drug Metab Pharmacokinet. 23:7–12.
  • Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. 2008. Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Rel. 127:59–69.
  • El Maghraby GM. 2008. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants. Int J Pharm. 355:285–292.
  • El Maghraby GM. 2010. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition. Colloids Surf B Biointerfaces. 75:595–600.
  • El Maghraby GM, Ahmed AA, Osman MA. 2015. Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery. Saudi Pharm J. 23:67–74.
  • El Maghraby GM, Ahmed AA, Osman MA. 2014. Skin delivery of nisoldipine from niosome proconcentrate. J Appl Pham Sci. 4:112–117.
  • El Maghraby GM, Campbell M, Finnin BC. 2005. Mechanisms of action of novel skin penetration enhancers: phospholipid versus skin lipid liposomes. Int J Pharm. 305:90–104.
  • El Maghraby GM, Williams AC. 2009. Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin Drug Deliv. 6:149–163.
  • El Maghraby GM, Williams AC, Barry BW. 1999. Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol. 51:1123–1134.
  • El Maghraby GMM, Williams AC, Barry BW. 2000. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm. 196:63–74.
  • El Maghraby GMM, Williams AC, Barry BW. 2004. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm. 276:143–161.
  • Essa EA. 2010. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm. 4:227–233.
  • Essa EA, Bonner MC, Barry BW. 2002. Iontophoretic estradiol skin delivery and tritium exchange in ultradeformable liposomes. Int J Pharm. 240:55–66.
  • Essa EA, Bonner MC, Barry BW. 2004. Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. J Control Rel. 95:535–546.
  • Foco A, Gasperlin M, Kristl J. 2005. Investigation of liposomes as carriers of sodium ascorbyl phosphate for cutaneous photoprotection. Int J Pharm. 291:21–29.
  • Gök A, Kirbaşlar ŞI, Kirbaşlar FG. 2015. Comparison of lemon oil composition after using different extraction methods. J Essent Oil Res. 27:17–22.
  • Goodman M, Barry BW. 1988. Action of penetration enhancers on human skin as assessed by permeation of model drugs 5-fluorouracil and estradiol: I – infinite dose technique. J Invest Dermatol. 91:323–327.
  • Honeywell-Nguyen PL, Gooris GS, Bouwstra JA. 2004. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol. 123:902–910.
  • Jain AK, Thomas NS, Panchagnula R. 2002. Transdermal drug delivery of imipramine hydrochloride: I – effect of terpenes. J Control Rel. 79:93–101.
  • Kost J, Pliquett U, Mitragotri S, Yamamoto A, Langer R, Weaver J. 1996. Synergistic effect of electric field and ultrasound on transdermal transport. Pharm Res. 13:633–638.
  • Maestrelli F, Gonzalez-Rodrıguez ML, Rabasco AM, Mura P. 2005. Preparation and characterization of liposomes encapsulating ketoprofen–cyclodextrin complexes for transdermal drug delivery. Int J Pharm. 298:55–67.
  • Megrab NA, Williams AC, Barry BW. 1995. Oestradiol permeation across human skin and silastic membranes: effects of propylene glycol and supersaturation. J Control Rel. 36:277–294.
  • Mezei M, Gulasekharam V. 1980. Liposomes-a selective drug delivery system for topical route of administration: I – lotion dosage form. Life Sci. 26:1473–1477.
  • Miller LL, Kolaskie CJ, Smith GA, Rivier J. 1990. Transdermal iontophoresis of gonadotropin releasing hormone (LHRH) and two analogues. J Pharm Sci. 79:490–493.
  • Morimoto Y, Wada Y, Seki T, Sugibayashi K. 2002. In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and L-menthol. Biol Pharm Bull. 25:134–136.
  • Schreier H, Bouwstra J. 1994. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Rel. 30:1–15.
  • Shen Q, Li W, Li W. 2007. The effect of clove oil on the transdermal delivery of ibuprofen in the rabbit by in vitro and in vivo methods. Drug Dev Ind Pharm. 33:1369–1374.
  • Song A, Wang Y, Liu Y. 2009. Study on the chemical constituents of the essential oil of the leaves of Eucalyptus globulus Labill from China. Asian J Tradit Med. 4:134–140.
  • Sultan AA, El-Gizawy SA, Osman MA, El Maghraby GM. 2016. Colloidal carriers for extended absorption window of furosemide. J Pharm Pharmacol. 68:324–332.
  • Tahmasebi P, Javadpour F, Sahimi M. 2015. Three-dimensional stochastic characterization of shale SEM images. Transp Porous Med. 110:521–531.
  • Touitou E, Godin B, Weiss C. 2000. Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev Res. 50:406–415.
  • Trotta M, Peira E, Debernardi F, Gallarate M. 2002. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm. 241:319–327.
  • Vora B, Khopade AJ, Jain NK. 1998. Proniosome based transdermal delivery of levonorgesterol for effective contraception. J Control Rel. 54:149–165.
  • Williams AC, Barry BW. 1989. Essential oils as novel human skin penetration enhancers. Int J Pharm. 57:R7–R9.
  • Williams AC, Barry BW. 1991. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int J Pharm. 74:157–168.
  • Yamane MA, Williams AC, Barry BW. 1995. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J Pharm Pharmacol. 47:978–989.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.